CMS Q2 2026 HCPCS Update: 15 New Drug Codes for Oct. 1
CMS’s Q2 2026 HCPCS decisions add 15 new drug and biosimilar codes for October 1 and deny two closely watched revision requests.
·
CMS’s Q2 2026 HCPCS decisions add 15 new drug and biosimilar codes for October 1 and deny two closely watched revision requests.
·
Ebix’s new A.D.A.M. platform maps health content to ICD-10 and LOINC at scale. Here’s what automated coding at that volume means for medical coders and RCM teams.
·